Bank of America’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-90,600
Closed -$10.1M 7742
2025
Q3
$10.1M Buy
90,600
+31,100
+52% +$3.53M ﹤0.01% 3303
2025
Q2
$6.6M Sell
59,500
-112,700
-65% -$12M ﹤0.01% 3623
2025
Q1
$19.3M Sell
172,200
-44,500
-21% -$4.59M ﹤0.01% 2474
2024
Q4
$20M Buy
216,700
+62,500
+41% +$5.63M ﹤0.01% 2299
2024
Q3
$12.9M Sell
154,200
-2,400
-2% -$183K ﹤0.01% 2826
2024
Q2
$10.7M Sell
156,600
-112,800
-42% -$7.53M ﹤0.01% 2882
2024
Q1
$19.7M Sell
269,400
-62,600
-19% -$4.81M ﹤0.01% 2299
2023
Q4
$26.9M Buy
332,000
+81,700
+33% +$6.36M ﹤0.01% 1866
2023
Q3
$18.8M Buy
250,300
+33,900
+16% +$2.61M ﹤0.01% 2089
2023
Q2
$16.7M Sell
216,400
-73,800
-25% -$5.89M ﹤0.01% 2194
2023
Q1
$24.1M Sell
290,200
-225,600
-44% -$18.7M ﹤0.01% 1955
2022
Q4
$44.3M Buy
515,800
+4,300
+0.8% +$341K 0.01% 1385
2022
Q3
$31.6M Buy
511,500
+87,700
+21% +$5.53M ﹤0.01% 1604
2022
Q2
$26.2M Sell
423,800
-915,100
-68% -$56.7M ﹤0.01% 1777
2022
Q1
$79.6M Buy
1,338,900
+192,500
+17% +$12.3M 0.01% 1077
2021
Q4
$83.2M Buy
1,146,400
+421,900
+58% +$29.1M 0.01% 1084
2021
Q3
$50.6M Buy
724,500
+313,400
+76% +$22M 0.01% 1347
2021
Q2
$28.3M Sell
411,100
-37,800
-8% -$2.52M ﹤0.01% 1818
2021
Q1
$29M Sell
448,900
-89,000
-17% -$5.74M ﹤0.01% 1710
2020
Q4
$31.3M Buy
537,900
+216,700
+67% +$13.1M ﹤0.01% 1517
2020
Q3
$20.3M Sell
321,200
-336,800
-51% -$23.4M ﹤0.01% 1695
2020
Q2
$50.6M Sell
658,000
-212,000
-24% -$16.2M 0.01% 1016
2020
Q1
$65M Buy
870,000
+409,400
+89% +$28.3M 0.01% 814
2019
Q4
$29.9M Buy
460,600
+241,000
+110% +$15.7M ﹤0.01% 1542
2019
Q3
$13.9M Sell
219,600
-48,500
-18% -$3.17M ﹤0.01% 2175
2019
Q2
$18.1M Sell
268,100
-8,300
-3% -$546K ﹤0.01% 1956
2019
Q1
$18M Sell
276,400
-861,400
-76% -$57.3M ﹤0.01% 1922
2018
Q4
$71.2M Buy
1,137,800
+18,200
+2% +$1.27M 0.01% 821
2018
Q3
$86.4M Buy
1,119,600
+40,200
+4% +$3.04M 0.01% 797
2018
Q2
$76.5M Sell
1,079,400
-569,300
-35% -$40.2M 0.01% 830
2018
Q1
$124M Sell
1,648,700
-1,138,500
-41% -$90.5M 0.02% 631
2017
Q4
$200M Buy
2,787,200
+202,300
+8% +$15.4M 0.03% 448
2017
Q3
$209M Sell
2,584,900
-184,000
-7% -$14.1M 0.03% 458
2017
Q2
$196M Buy
2,768,900
+77,900
+3% +$5.18M 0.04% 431
2017
Q1
$183M Sell
2,691,000
-135,500
-5% -$9.53M 0.04% 439
2016
Q4
$202M Buy
2,826,500
+136,900
+5% +$10.2M 0.04% 408
2016
Q3
$213M Buy
2,689,600
+506,600
+23% +$41.2M 0.05% 382
2016
Q2
$182M Buy
2,183,000
+496,100
+29% +$44M 0.04% 416
2016
Q1
$155M Sell
1,686,900
-203,700
-11% -$18.4M 0.04% 448
2015
Q4
$191M Sell
1,890,600
-48,300
-2% -$5.03M 0.05% 413
2015
Q3
$190M Buy
1,938,900
+187,500
+11% +$20.8M 0.05% 408
2015
Q2
$205M Buy
1,751,400
+236,200
+16% +$25.8M 0.07% 311
2015
Q1
$149M Sell
1,515,200
-1,455,700
-49% -$148M 0.05% 376
2014
Q4
$280M Buy
2,970,900
+579,800
+24% +$60M 0.1% 229
2014
Q3
$255M Buy
2,391,100
+510,200
+27% +$50M 0.08% 255
2014
Q2
$156M Buy
1,880,900
+925,200
+97% +$72M 0.05% 397
2014
Q1
$67.7M Sell
955,700
-677,300
-41% -$53.1M 0.03% 630
2013
Q4
$123M Sell
1,633,000
-123,700
-7% -$8.61M 0.04% 421
2013
Q3
$110M Sell
1,756,700
-121,300
-6% -$7.25M 0.04% 428
2013
Q2
$96.3M Buy
+1,878,000
New +$97.9M 0.04% 430

Other funds holding GILD

Bank of America's GILD Position: Q1 2026 in Review

Bank of America reduced its Gilead Sciences (GILD) stake by 14% in Q1 2026, selling an estimated $440M and leaving 19,978,936 shares worth $2.78B. The position accounts for 0.2% of the portfolio, ranked #98.

Bank of America first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.84B in Q4 2025. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bank of America held 19,978,936 shares of Gilead Sciences worth $2.78B as of Q1 2026.
  • Bank of America sold 3,142,684 Gilead Sciences shares in Q1 2026, an estimated $440M.
  • Gilead Sciences made up 0.2% of Bank of America's portfolio in Q1 2026, its #98 holding.
  • Bank of America first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Gilead Sciences position peaked at $2.84B in Q4 2025.
  • 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.